OPIANT PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2020

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2020.
  • Opiant Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $800K, a 300% increase year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $200K.
  • Opiant Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2017 was $981K, a 90.4% decline from 2016.
  • Opiant Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2016 was $10.2M, a 913% increase from 2015.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2020 $200K Jan 1, 2020 Dec 31, 2020 10-K 2021-03-04
2017 $981K -$9.23M -90.4% Aug 1, 2016 Jul 31, 2017 10-K 2017-10-13
2016 $10.2M +$9.2M +913% Aug 1, 2015 Jul 31, 2016 10-K 2017-10-13
2015 $1.01M -$7.28M -87.8% Aug 1, 2014 Jul 31, 2015 10-K 2015-10-26
2014 $8.28M +$1.41M +20.6% Aug 1, 2013 Jul 31, 2014 10-K 2015-10-26
2013 $6.87M +$6.34M +1193% Aug 1, 2012 Jul 31, 2013 10-K 2014-10-27
2012 $531K $0 0% Aug 1, 2011 Jul 31, 2012 10-Q 2013-06-14
2011 $531K Aug 1, 2010 Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.